The cash recovery method of calculating profitability: An application to pharmaceutical firms

Review of Industrial Organization

Volumn 14, Issue 2, 1999, Pages 135-146

  Taylor, Christopher T ^a  

^a United States International Trade Commission   (United States)

Author keywords

Market performance; Pharmaceuticals; Profitability

Indexed keywords

ECONOMIC THEORY; INVESTMENT; PHARMACEUTICAL INDUSTRY; PROFITABILITY;

EID: 0032897846     PISSN: 0889938X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007723726138     Document Type: Article

References (27)

1. Bain, J. (1941) 'The Profit Rate as a Measure of Monopoly Power', Quarterly Journal of Economics, 55, 271-293.
2. Baber, W. R., and S.-H. Kang (1991) 'Accounting-Based Measures as Estimates of Economic Rates of Return: An Empirical Study of the U.S. Pharmaceutical Industry 1976-87', Draft paper prepared for the Office of Technology Assessment, U.S. Congress, Washington, D.C.
3. Clarkson, K. W. (1977) Intangible Capital and Rates of Return: Effects of Research and Promotion on Profitability. Washington, D.C.: American Enterprise Institute.
4. Dimasi, J. A., R. W. Hansen, H. G. Grabowski et al. (1991) 'The Cost of Innovation in the Pharmaceutical Industry', Journal of Health Economics, 10, 107-142.
5. Fisher, F., and J. McGowan (1983) 'On the Misuse of Accounting Rates of Return to Infer Monopoly Profits', American Economic Review, 73, 82-97.
6. Grabowski, H., and D. Mueller (1978) 'Industrial Research and Development, Intangible Capital Stocks and Profit Rates', The Bell Journal of Economics, 9, 328-343.
7. Grabowski, H., and J. Vernon (1990) 'Return and Risk and R & D', Management Science, 36, 804-821.
8. Grabowski, H., and J. Vernon (1992) 'Brand Loyalty, Entry and Price Competition in Pharmaceutical After the 1984 Drug Act', Journal of Law and Economics, 35, 331-350.
9. Grabowski, H., and J. Vernon (1994) 'Returns to R & D on New Drug Introductions in the 1980's', Journal of Health Economics, 13, 383-406.
10. Hirschey, M., and J. Weygandt (1985) 'Amortization Policy for Advertising and Research and Development Expense', Journal of Accounting Research, 22, 326-335.
11. Ijiri, Y. (1978) 'Cash Flow Accounting and its Structure', Journal of Accounting, Auditing and Finance, 1, 331-348.
12. Ijiri, Y. (1979) 'Convergence of the Cash Recovery Rate', in Y. Ijiri and A. Whinston, eds., Quantitative Planning and Control. New York: Academic Press, pp. 259-267.
13. Ijiri, Y (1980) 'Recovery Rate and Cash Flow Accounting', Financial Executive, 48, 54-60.
14. Joglekar, P., and M. Paterson (1986) 'A Closer Look at the Returns and Risk of Pharmaceutical Research and Development', Journal of Health Economics, 5, 153-177.
15. Lee, T. A., and A. W. Stark (1987) 'Ijiri's Cash Flow Accounting and Capital Budgeting', Accounting and Business Research, 17, 125-132.
16. Long, W. F., and D. J. Ravenscraft (1984) 'The Misuse of Accounting Rates of Return', American Economic Review, 74, 494-500.
17. Mattison, N., A. G. Trimble, and L. Lasagna (1988) 'New Drug Development in the United States, 1963-1984', Clinical Pharmacology and Therapies, 43, 290-301.
18. Myers, S. C., and L. Shyam-Sunder (1991) 'Costs of Capital Estimates for Investment in Pharmaceutical Research and Development', Contract report prepared for the Office of Technology Assessment, U.S. Congress, Washington, D.C.
19. Salamon, G. L. (1982) 'Cash Recovery Rate and Measures of Firms Profit', The Accounting Review, 57, 292-302.
20. Salamon, G. L. (1985) 'Accounting Rates of Return', American Economic Review, 75, 495-504.
21. Salamon, G. L. (1988) 'On the Validity of Accounting Rate of Return in Cross Sectional Analysis: Theory, Evidence, and Implications', Journal of Accounting and Public Policy, 7, 267-292.
22. Scherer, F. M. (1993) 'Pricing, Profits, and Technological Progress in the Pharmaceutical Industry', Journal of Economic Perspectives, 7, 97-115.
23. Schmalensee, R. (1989) 'Studies of Structure and Performance', in R. Schmalensee and R. Willig, eds., Handbook of Industrial Organization. Amsterdam: North Holland.
24. Shinnar, R., O. Dressler, C. A. Feng, and A. Avidan (1989) 'Estimates of the Economic Rate of Return for Industrial Companies', Journal of Business, 62, 417-445.
25. Stark, A. W. (1987) 'On the Observability of the Cash Recovery Rate', Journal of Business, Finance and Accounting, 14, 99-108.
26. Taylor, C. (1994) An Inquiry into Firm Profitability Using the Cash Recovery Method: An Application to Pharmaceuticals. Ph.D. Dissertation, Duke University.
27. U.S. Congress, Office of Technology Assessment (1993) Pharmaceutical R & D: Costs, Risks and Rewards. OTA-H-522 Washington, D.C.: U.S. Government Printing Office.